An mRNA drug reengineers stem cells
Scientists developed an alternative to bone marrow transplantation by using technology similar to that of the COVID-19 mRNA vaccines.
lipid nanoparticle
The versatile value of mRNA vaccines
Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.
